Rheumatoid Arthritis News: Actemra Approved
New medicine for unresponsive Rheumatoid Arthritis in the news
Friday, the U.S. Food and Drug Administration (FDA) approved Actemra (Tocilizumab) to treat severe RA in patients who did not respond to TNF blocking medicines like Enbrel and Humira and other disease modifying drugs DMARDs. Associated Press reports: Hal Barron, chief medical officer for Genentech, a division...Continue reading 42 Comments »
Read more